Kevin F McLaughlin

Director

Kevin F McLaughlin (Director) filed 5 Form 4 reports in the trailing twelve months (1 purchase, 4 sales), most often in Vericel Corporation (VCEL). Across 1 priced purchase filing, the average 21-session return was -9.8% from execution and -10.5% from disclosure (delay-adjusted; derived). The largest single filing was $312K of VCEL (7,000 sh × $44.53, as filed), executed Aug 12.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-9.8%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-10.5%

same 1 filings, from disclosure

Filings, ttm

1 buys · 4 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.2M

shares × price, as filed

Last traded

Aug 12

Filed Aug 14

Median ADV $25.7M across their filed names

Open performance→

Volume by month

Buys $125K Sells $2.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names

VCEL

Vericel Corporation VCEL · 0 buys · 8 sells 8 filings IVVD IVVD IVVD · 1 buy · 0 sells 1 filing

Recent filings

VCELSALE Vericel Corporation View filing → $389K
7,000 sh × $55.54
Exec Nov 13 2024
Filed Nov 15 2024 · 5:30 PM ET